TY - JOUR AU - Shokoofeh, Siroosi AU - Homa, Manaheji AU - Leila, Dargahi AU - Samira, Daniali TI - Expression of spinal cord GABA transporter 1 in morphine-tolerant male Wistar rats JF - EUROPEAN JOURNAL OF PHARMACOLOGY J2 - EUR J PHARMACOL VL - 767 PY - 2015 SP - 77 EP - 81 PG - 5 SN - 0014-2999 DO - 10.1016/j.ejphar.2015.10.010 UR - https://m2.mtmt.hu/api/publication/25284847 ID - 25284847 LA - English DB - MTMT ER - TY - JOUR AU - Simon, EJ AU - Onoprishvili, I TI - The Interaction Between the Mu Opioid Receptor and Filamin A JF - NEUROCHEMICAL RESEARCH J2 - NEUROCHEM RES VL - 35 PY - 2010 IS - 12 SP - 1859 EP - 1866 PG - 8 SN - 0364-3190 DO - 10.1007/s11064-010-0261-9 UR - https://m2.mtmt.hu/api/publication/22153742 ID - 22153742 N1 - DI: 10.1007/s11064-010-0261-9 LA - English DB - MTMT ER - TY - JOUR AU - OnoprishVili, I AU - Simon, EJ TI - Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A JF - BRAIN RESEARCH J2 - BRAIN RES VL - 1177 PY - 2007 IS - 1 SP - 9 EP - 18 PG - 10 SN - 0006-8993 DO - 10.1016/j.brainres.2007.08.020 UR - https://m2.mtmt.hu/api/publication/22153761 ID - 22153761 LA - English DB - MTMT ER - TY - JOUR AU - Chakrabarti, S AU - Regec, A AU - Gintzler, AR TI - Biochemical demonstration of mu-opioid receptor association with Gs alpha: enhancement following morphine exposure JF - MOLECULAR BRAIN RESEARCH J2 - MOL BRAIN RES VL - 135 PY - 2005 IS - 1-2 SP - 217 EP - 224 PG - 8 SN - 0169-328X DO - 10.1016/j.molbrainres.2004.12.016 UR - https://m2.mtmt.hu/api/publication/22186886 ID - 22186886 LA - English DB - MTMT ER - TY - JOUR AU - Gu, YP AU - Xu, Y AU - Li, GW AU - Huang, LYM TI - Remote nerve injection of mu opioid receptor adeno-associated viral vector increases antinociception of intrathecal morphine JF - JOURNAL OF PAIN J2 - J PAIN VL - 6 PY - 2005 IS - 7 SP - 447 EP - 454 PG - 8 SN - 1526-5900 DO - 10.1016/j.jpain.2005.02.005 UR - https://m2.mtmt.hu/api/publication/21874151 ID - 21874151 LA - English DB - MTMT ER - TY - JOUR AU - Ray, SB AU - Gupta, YK AU - Wadhwa, S TI - Expression of opioid receptor-like 1(ORL1) & mu opioid receptors in the spinal cord of morphine tolerant mice JF - INDIAN JOURNAL OF MEDICAL RESEARCH J2 - INDIAN J MED RES VL - 121 PY - 2005 IS - 3 SP - 194 EP - 202 PG - 9 SN - 0971-5916 UR - https://m2.mtmt.hu/api/publication/21874153 ID - 21874153 LA - English DB - MTMT ER - TY - JOUR AU - Simpson, GR AU - Riley, AL TI - Morphine preexposure facilitates morphine place preference and attenuates morphine taste aversion JF - PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR J2 - PHARMACOL BIOCHEM BE VL - 80 PY - 2005 IS - 3 SP - 471 EP - 479 PG - 9 SN - 0091-3057 DO - 10.1016/j.pbb.2005.01.003 UR - https://m2.mtmt.hu/api/publication/21874152 ID - 21874152 LA - English DB - MTMT ER - TY - JOUR AU - Bodnar, RJ AU - Klein, GE TI - Endogenous opiates and behavior: 2003 JF - PEPTIDES J2 - PEPTIDES VL - 25 PY - 2004 IS - 12 SP - 2205 EP - 2256 PG - 52 SN - 0196-9781 DO - 10.1016/j.peptides.2004.09.005 UR - https://m2.mtmt.hu/api/publication/25119336 ID - 25119336 N1 - Cited By :44 Export Date: 1 July 2021 CODEN: PEPTD Correspondence Address: Dept. of Psychol. and Neuropsychol., United States; email: richard_bodnar@qc.edu Chemicals/CAS: 1 (1 cyclooctylmethyl 3 hydroxymethyl 4 piperidyl) 3 ethyl 1,3 dihydro 2h benzimidazol 2 one, 256640-45-6; 1 (2,3 dihydro 1 methyl 2 oxo 5 phenyl 1h 1,4 benzodiazepin 3 yl) 3 (3 methylphenyl)urea, 118101-09-0; 1 (2,4 dichlorophenyl) 5 (4 iodophenyl) 4 methyl n (1 piperidyl) 1h pyrazole 3 carboxamide, 183232-66-8; 1 (4 aminophenyl) 3,4 dihydro 4 methyl 3 methylcarbamoyl 7,8 methylenedioxy 5h 2,3 benzodiazepine, 143692-48-2; 1,4 diamino 1,4 bis(2 aminophenylthio) 2,3 dicyanobutadiene, 109511-58-2; 2 [1 (3 dimethylaminopropyl) 3 indolyl] 3 (3 indolyl)maleimide, 133052-90-1; 2 morpholino 8 phenylchromone, 154447-36-6; 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine, 67287-49-4; 3 (difluoromethyl) 1 (4 methoxyphenyl) 5 [4 (methylsulfinyl)phenyl]pyrazole, 151506-44-4; 3,4 dichloro n methyl n [2 (1 pyrrolidinyl)cyclohexyl]benzeneacetamide, 67198-13-4; 3,4 dichloro n methyl n [2 (1 pyrrolidinyl)cyclohexyl]benzeneacetamide methanesulfonate, 83913-06-8; 4 (1,1 dimethylheptyl) 1',2',3',4',5',6' hexahydro 2,3' dihydroxy 6' (3 hydroxypropyl)biphenyl, 83003-12-7; 4 [alpha (4 allyl 2,5 dimethyl 1 piperazinyl) 3 methoxybenzyl] n,n diethylbenzamide, 156727-74-1; 5 amino 2 (2 furyl) 7 (2 phenylethyl)pyrazolo[4,3 e][1,2,4]triazolo[1,5 c]pyrimidine, 160098-96-4; 5 dimethylamino n (3,4 dimethyl 5 isoxazolyl) 1 naphthalenesulfonamide, 153042-42-3; 6 chloro 2,3,4,5 tetrahydro 3 methyl 1h 3 benzazepine, 73943-10-9; 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate, 87134-87-0; bemesetron, 40796-97-2; brefeldin A, 20350-15-6; brimonidine, 59803-98-4; bupivacaine, 18010-40-7, 2180-92-9, 55750-21-5; buprenorphine, 52485-79-7, 53152-21-9; butorphanol, 42408-82-2; calphostin C, 121263-19-2; codeine, 76-57-3; cyclazocine, 3572-80-3; cyclo(dextro tryptophyl dextro aspartylprolyl dextro valylleucyl), 136553-81-6; decahydro 6 phosphonomethyl 3 isoquinolinecarboxylic acid, 136109-04-1, 137433-06-8; dezocine, 53648-55-8; dihydrocodeine, 125-28-0, 24204-13-5, 5965-13-9; dizocilpine, 77086-21-6; docebenone, 80809-81-0; endorphin, 60118-07-2; etorphine, 13764-49-3, 14521-96-1; fentanyl, 437-38-7; hydromorphone, 466-99-9, 71-68-1; kt 5720, 108068-98-0; lofentanil, 61380-40-3; metazocine, 3734-52-9; mifepristone, 84371-65-3; morphine, 52-26-6, 57-27-2; n [2 [4 (2 methoxyphenyl) 1 piperazinyl]ethyl] n (2 pyridyl)cyclohexanecarboxamide, 146714-97-8; n [2 [[n [3 (4 chlorophenyl) 2 propenyl] n methylamino]methyl]phenyl] n (2 hydroxyethyl) 4 methoxybenzenesulfonamide, 139298-40-1; n acetyl alpha intermedin[4-10]cyclo[4 norleucine 5 aspartic acid 7 [3 (2 naphthyl)alanine] 10 lysinamide], 168482-23-3; n methyl n [7 (1 pyrrolidinyl) 1 oxaspiro[4.5]dec 8 yl]benzeneacetamide, 96744-75-1; nalbuphine, 20594-83-6, 23277-43-2; nalfurafine, 152657-84-6, 152658-17-8; nalorphine, 1041-90-3, 57-29-4, 62-67-9; naloxone, 357-08-4, 465-65-6; naltrexone, 16590-41-3, 16676-29-2; oxycodone, 124-90-3, 76-42-6; pethidine, 28097-96-3, 50-13-5, 57-42-1; piritramide, 302-41-0; rimonabant, 158681-13-1, 168273-06-1; saredutant, 142001-63-6; tacrolimus, 104987-11-3; Opioid Peptides; Receptors, Opioid Tradenames: aa 861; am 251; bms 182874; bp 897; bq 123; cgrp8 37; cgs 10764b; chf 3381; cp 55940; dpi 3290; f 13640; fk 506; fr 140423; gf 109203x; go 7874; j 113397; jct 801; kn 93; kt 5720; l 365260; ly 235959; ly 274614; ly 294002; ly 300168; ly 306740; mdl 72222; mk 801; r 004333; r 820; rb 3007; ro 646198; ru 486; sch 23390; sch 58261; shu 9119; skf 38393; skf 86466; snc 80; sr 141716a; sr 48968; trk 20; trk 820; u 0126; u 50488; u 50488h; u 69563; u 69593; uk 14304; way 100635; win 55212 2 LA - English DB - MTMT ER -